Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding.

[1]  A. Lusky,et al.  Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrate. , 1995, The Annals of thoracic surgery.

[2]  O. Wenker,et al.  EFFECT OF ADDING FRESH FROZEN PLASMA TO THE CARDIOPULMONARY BYPASS MACHINE ON BLOOD COMPONENT REQUIREMENTS IN COMPLEX CV PROCEDURES , 1995 .

[3]  J. Lemmer.  Reporting the results of blood conservation studies: the need for uniform and comprehensive methods. , 1994, The Annals of thoracic surgery.

[4]  J. Klemperer,et al.  Combined aprotinin and erythropoietin use for blood conservation: results with Jehovah's Witnesses. , 1994, The Annals of thoracic surgery.

[5]  G. Guiraudon,et al.  Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. , 1994, The Journal of thoracic and cardiovascular surgery.

[6]  A. Weaver,et al.  Autologous Platelet-rich Plasma Does Not Reduce Transfusion of Homologous Blood Products in Patients Undergoing Repeat Valvular Surgery , 1993, Anesthesiology.

[7]  E. Verrier,et al.  Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study. , 1993, The Journal of thoracic and cardiovascular surgery.

[8]  R. Mohr,et al.  Is transfusion of fresh plasma after cardiac operations indicated? , 1990, The Journal of thoracic and cardiovascular surgery.

[9]  W. van Oeveren,et al.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[10]  S. Bhakdi,et al.  Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass. , 1988, The New England journal of medicine.

[11]  R. Wilson,et al.  Hemostasis Changes During Cardiopulmonary Bypass Surgery , 1985, Seminars in thrombosis and hemostasis.

[12]  T. Simon,et al.  Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. , 1984, The Annals of thoracic surgery.

[13]  M. Kutner,et al.  Autologous blood transfusion during cardiac surgery. A re-evaluation of three methods. , 1977, The Journal of thoracic and cardiovascular surgery.

[14]  N. Mills,et al.  Fresh Autologous Blood Transfusions with Extracorporeal Circulation , 1973, Annals of surgery.

[15]  D. Gibson,et al.  COMPARISON OF CHANGES IN LEFT-VENTRICULAR FUNCTION IMMEDIATELY AFTER AORTIC-VALVE REPLACEMENT USING CRYSTALLOID, COLD OR WARM BLOOD CARDIOPLEGIA , 1994 .

[16]  S. Neubauer,et al.  CHRONIC BETA-BLOCKER TREATMENT FOLLOWING MYOCARDIAL-INFARCTION REVERSES BIOCHEMICAL REMODELING OF NONINFARCTED TISSUE , 1993 .

[17]  G. Moroff,et al.  Concepts about current conditions for the preparation and storage of platelets. , 1991, Transfusion medicine reviews.

[18]  D. Roberts,et al.  Evaluation of red cell damage during cardiopulmonary bypass. , 1985, Scandinavian journal of thoracic and cardiovascular surgery.

[19]  S. Albert,et al.  Blood volume and extracellular fluid volume , 1971 .

[20]  J. Nyboer,et al.  The use of the heart-lung apparatus in human cardiac surgery. , 1957, The Journal of thoracic surgery.